Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat dermatological disorders.
Latest News
Dermatology
Blueberry is committed to the development of innovative new therapies for the treatment of common dermatological disorders.
Nanomedicine
We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.
News
Stamping out Athlete’s foot
Written by Heather Davies-Strickleton, Senior Analytical Scientist Running into trouble: Athlete’s foot is a common problem Athlete’s foot needs no [...]
Blueberry Therapeutics completes BB2603 Investigator meeting
The Blueberry Therapeutics project team along with CEO John Ridden, and their partner Iqvia Biotech, held an Investigator meeting [...]
A Blueberry case study
In this video, CEO John Ridden and CSO David Cook talk about the early days of Blueberry Therapeutics, the short term and long term plans for the company, and the benefits of being based at Alderley Park, Cheshire.